ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy
Authors:
- Roberto D’aNgeloRDRoberto D’aNgelo
- Rita RinaldiRRRita Rinaldi
- Valerio CarelliValerio Carelli
- Elisa BoschettiEBElisa Boschetti
- Leonardo CaporaliLCLeonardo Caporali
- Mariantonietta CapristoMCMariantonietta Capristo
- Carlo CasaliCCCarlo Casali
- Giovanna CenacchiGCGiovanna Cenacchi
- Laura Ludovica GramegnaLGLaura Ludovica Gramegna
- Raffaele LodiRLRaffaele Lodi
- Loris PironiLPLoris Pironi
- 23 March 2016
- journal article
- research article
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (7) , 1149-1151
Abstract
Mitochondrial neuro-gastro-intestinal encephalomyopathy (MNGIE) is a rare and unavoidably fatal disease due to mutations in thymidine phosphorylase (TP). Clinically it is characterized by gastrointestinal dysfunction, malnutrition/cachexia and neurological manifestations. MNGIE diagnosis remains a challenge mainly because of the complexity and rarity of the disease. Thus, our purposes were to promote a better knowledge of the disease in Emilia-Romagna region (ERR) by creating an accurate and dedicated network; to establish the minimal prevalence of MNGIE in Italy starting from ERR. Blood TP activity level was used as screening test to direct candidates to complete diagnostic work-up. During the study period of 1 year, only 10/71 units of ERR recruited 14 candidates. Their screening did not show TP activity changes. An Italian patient not resident in ERR was actually proved to have MNGIE. At the end of study in Italy there were nine cases of MNGIE; thus, the Italian prevalence of the disease is ~0.15/1,000,000 as a gross estimation. Our study confirms that MNGIE diagnosis is a difficult process which reflects the rarity of the disease and, as a result, a low level of awareness among specialists and physicians. Having available novel therapeutic options (e.g., allogenic hematopoietic stem cell transplantation and, more recently, liver transplantation) and an easy screening test, an early diagnosis should be sought before tissue damage occurs irreversibly.Keywords
Funding Information
- Ministero della Salute (ItaMNGIE grant Ricerca Finalizzata RF-2009)
- Fondazione del Monte di Bologna e Ravenna
This publication has 7 references indexed in Scilit:
- Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathyBrain, 2015
- Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal EncephalomyopathyPLOS ONE, 2014
- Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathyJournal of Inherited Metabolic Disease, 2011
- Definitive Diagnosis of Mitochondrial Neurogastrointestinal Encephalomyopathy by Biochemical AssaysClinical Chemistry, 2004
- Review of the prevalence and incidence of eating disordersInternational Journal of Eating Disorders, 2003
- Thymidine Phosphorylase Gene Mutations in MNGIE, a Human Mitochondrial DisorderScience, 1999
- Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)Neurology, 1994